WTO/AIDS

Ian Murray seamus2001 at home.com
Mon Jun 25 12:06:36 PDT 2001


Monday June 25, 1:34 pm Eastern Time U.S. Withdraws WTO Patents Case U.S. Withdraws WTO Patents Case Against Brazil Over Law to Ensure Cheap AIDS Drugs By NAOMI KOPPEL Associated Press Writer

GENEVA (AP) -- The United States has withdrawn a complaint with the World Trade Organization over a law used by Brazil to ensure cheap drugs to fight AIDS, a Brazilian trade negotiator said Monday.

Jose Alfredo Graca Lima told reporters the two countries had ``come to an understanding'' over a law that requires owners of Brazilian patents to manufacture their products in Brazil rather than import them. If this is not done, the law gives the Brazilian government the right to license the manufacturing rights to another producer.

``It is a victory for both sides, a victory for common sense,'' he said.

U.S. Trade Representative Robert Zoellick, speaking in Washington, insisted the U.S. case had nothing to do with AIDS drugs. Under WTO rules, there are procedures for governments to force local production of patented drugs if the country is experiencing a health emergency like the HIV/AIDS epidemic, he said.

The United States went to the WTO in February to complain that Brazil's 1996 industrial property law violates patent protection rules.

Brazil maintained that its laws are acceptable under WTO rules.

The Nobel Prize-winning charity Medicins Sans Frontieres -- also known as Doctors Without Borders -- said the Brazilian government's program allowed it to offer free treatment to more than 90,000 patients, and this would be threatened if Brazil had to accept higher-priced imported drugs.

Graca Lima said Brazil had agreed with Washington that it would give 10 days' notice before it used compulsory licensing under the law, to give time for consultations.

The WTO agreed last week to look into whether its rules protecting drug patents can become more flexible to address concerns by developing countries and health activists that the regulations prevent vital medicines reaching the poor.



More information about the lbo-talk mailing list